HISAMITSU PHARMACEUTICAL CO. INC. revenue for the last year amounted to 141.71 B JPY, the most of which — 138.46 B JPY — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 125.20 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought HISAMITSU PHARMACEUTICAL CO. INC. 81.03 B JPY, and the year before that — 74.64 B JPY.